Lessening Addiction By Enhancing Labeling (LABEL) Opioids Act of 2019 (HR 2732, 116th Congress)

Policy Details

Policy Details

Originating Entity
Last Action
Referred to Subcommittee
Date of Last Action
Jun 26 2019
Congressional Session
116th Congress
Date Introduced
May 14 2019
Publication Date
Jun 3 2019

SciPol Summary

The Lessening Addiction By Enhancing Labeling (LABEL) Opioids Act of 2019 (HR 2732 / S 1449, 116th Congress) would amend the Controlled Substances Act (21 U.S.C. 825(c)) to require opioid drugs to carry a clear and prominent label that they “can cause dependence, addiction, and overdose.” The Act further grants the Department of Health and Human Services with regulatory power to implement such labeling standards.

The ongoing opioid crisis in the US is estimated to cause 130 deaths per day. A number of legislative proposals, including this Act, seek to reduce rates of dependence and overdose on opioids.

SciPol Summary authored by